Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fukeyangrong capsule is a Traditional Chinese Medicine (TCM) formulation developed by Xi'an Ande Pharmaceutical for the treatment of gynecological disorders. It is composed of multiple herbal extracts, including Angelica sinensis, Rehmannia glutinosa, and Panax ginseng, which are traditionally used to nourish blood, tonify the kidney, and regulate menstruation. The drug is primarily indicated for women with kidney deficiency and blood stasis, particularly those experiencing diminished ovarian reserve and infertility. Clinical research has evaluated its efficacy as both a standalone treatment and an adjuvant to hormone replacement therapy to improve ovarian function and reproductive outcomes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fukeyangrong capsule.